Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2003 / Cilt: 29 - Sayı: 4

Does the presence of hypertension affect haemorrhage in patients undergoing transurethral resection of the prostate?

Transüretral prostat rezeksiyonu uygulanan olgularda hipertansiyon varlığı kanamayı etkiler mi?

Pages
465–469
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study demonstrated that when compared with normotensive patients, hypertensive patients with symptomatic BPH undergoing TURP does not have additional morbidity related to blood loss when the blood pressure was undercontrol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to investigate whether there was an effect of hypertension on haemorrhage in patients with symptomatic benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP).
📊
Key Findings & Data:Materials and Methods: Between January 2000 and December 2002, 91 patients with symptomatic BPH undergoing TURP were enrolled in the study, and the patients were divided into two groups; concomitant hypertension (n=25) and normotension (n=66).
💡
Conclusion & Impact:Conclusion: Our study demonstrated that when compared with normotensive patients, hypertensive patients with symptomatic BPH undergoing TURP does not have additional morbidity related to blood loss when the blood pressure was undercontrol.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Hipertansiyon · Kanama · Prostat hiperplazisi

Abstract

Introduction: The aim of this study was to investigate whether there was an effect of hypertension on haemorrhage in patients with symptomatic benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP). Materials and Methods: Between January 2000 and December 2002, 91 patients with symptomatic BPH undergoing TURP were enrolled in the study, and the patients were divided into two groups; concomitant hypertension (n=25) and normotension (n=66). All patients were assessed at baseline using age, International Prostate Symptom Score (IPSS), prostate volume and maximum urine flow rate (Qmax). Pre and postoperative blood tests including red blood cells (RBC), haematocrit and haemoglobin concentrations were recorded in all patients. Operating time, duration of chateterization and the changes of the blood parameters after TURP were compared between the normotensive and hypertensive patients. Results: There were no significantly differences in baseline characteristics between the normotensive and hypertensive patients (p>0.05). Blood parameters significantly decreased after TURP in the both normotansive and hypertensive patients (p<0.001). There were no significantly differences in operating time, duration of chateterization and the postoperative changes of the blood parameters between the normotensive and hypertensive patients (p>0.05, for each parameter). Conclusion: Our study demonstrated that when compared with normotensive patients, hypertensive patients with symptomatic BPH undergoing TURP does not have additional morbidity related to blood loss when the blood pressure was undercontrol.

Özet

Bu çalışmanın amacı semptomatik benin prostat hiperplazisi (BPH) nedeniyle transüretral prostat rezeksiyonu (TURP) yapılan olgularda hipertansiyon varlığının kanama üzerine etkisi olup olmadığını araştırmaktır. Ocak.2000 ve Aralık 2002 tarihleri arasında, semptomatik BPH nedeniyle TURP uygulanan 91 olgu çalışmaya alınarak 25'i hipertansif, 66'sı normotansif olarak 2 gruba ayrıldı. Operasyon öncesinde olguların hepsinde yaş, uluslar arası prostat semptom skoru (IPSS), prostat hacmi ve maksimum idrar akım hızı (Qmax) değerlendirmesi yapıldı. Tüm olgularda operasyon öncesi ve sonrasında eritrosit, hematokrit ve hemoglobin konsantrasyonlarını içeren kan parametreleri kaydedildi. Normotansif ve hipertansif olgularda, operasyon süresi, kateterizasyon süresi ve TURP sonrası kan parametrelerindeki değişimler karşılaştırıldı. Operasyon öncesi değerlerde normotansif ve hipertansif hastalar arasında fark izlenmedi (p>0.05). TURP sonrası hem normotansif hem de hipertansif olgularda kan parametrelerinde düşme görüldü (pO.OOl). Normotansif ve hipertansif olgularda operasyon süresi, kateterizasyon süresi ve TURP sonrası kan parametrelerindeki değişimler yönünden fark izlenmedi (p>0.05). Çalışmamızın sonuçlan, semptomatik BPH nedeniyle TURP uygulanacak hipertansif olguların kan basınçları kontrol altına alındığında, normotansif hastalara göre kanamayla ilgili ek morbiditeye sahip olmayacaklarını göstermektedir.

🔖

Cite This Article

ULUSOY, E., BOZLU, M., DORUK, N., ABİDİNOĞLU, D., ÇAYAN, S., AKBAY, E. (2003). Does the presence of hypertension affect haemorrhage in patients undergoing transurethral resection of the prostate?. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 29 - Sayı: 4, 465–469. https://ajindex.com/articles/328840

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Mebust WK, Holtgrawe HL, Cockett ATL, et al: Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol. 141: 243-247, 1989 2- Kirby RS: The natural history of benign prostatic hyperplasia: What have we learned in the last decade? Urology 56: 3-6, 2000 3- Malhotra V: Transurethral resection of the prostate. Anesthesiol Clin North America 18: 883-897, 2000 4- Ulusoy E, Öztürk B, Göğüş N, et al: Suprapubik transvezikal prostatektomide preoperatif fiziksel durumun postoperatif morbidite ve mortaliteye etkisi. Üroloji Bülteni 6: 74-76, 1995 5- Pientka L, van Loghem J, Hahn E, et al: Comorbidities and perioperative complications a-mong patients with surgically treated benign prostatic hyperplasia. Urology 38: 43-48, 1991 6- Boyle P, Napalkov P: The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand J Urol Nephrol. 168 (Suppl): 7-12, 1995 7- Mauermayer W: Transurethral Surgery. Sprin-ger-Verlag Berlin Heidelberg New York, 78-82, 1983 8- Tinker JH, Roberts SL: Anesthesia risk
  2. in Miller RD (eds): Anesthesia, Churchill Livingstone, New York, 359-380, 1986 9- Mikhail MS, Morgan GE: Clinical Anesthesiology, New Jersey, McGraw Hill, 341-347, 1996 10- Genç A, Ateş Y: Hipertansiyon ve anestezi
  3. in Özatamer O, Alkış N, Batislam Y, Yörükoğlu Küçük D (eds): Anestezide Güncel Konular, 269-291, 2002 11- Öztürk A, Koşar A, Serel TA, et al: Türkiye’ de 48 hastanenin verilerine göre benin prostat hiper-plazisi prevalansı ve uygulanan tedavi yöntemleri. Türk Üroloji Dergisi 24: 402-407, 1998 12- Neal DE: The National Prostatectomy Audit. Br J Urol. 79 (Suppl. 2): 69-75, 1997 13- Uchida T, Ohori M, Soh S, et al: Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 53: 98-105, 1999 14- Krillos MM, Campbell N: Factors influencing blood loss in transurethral resection of the prostate (TURP): auditing TURP. Br J Urol. 80: 111-115, 1997 15- Olapade-Olaopa BO, Solomon LZ, Carter CJM, et al: Hematuria and clot retention after transurethral resection of the prostate: A pilot study. BJU Int. 82: 624-627, 1998 16- Koşar A, Aslan P, Serel TA, et al: Transüretral prostat rezeksiyonunun kan kuagulasyon testleri üzerine etkisi. Türk Üroloji Dergisi 25: 323-327, 1999